Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference
Bicycle Therapeutics Initiated at Equal-Weight by Stephens & Co.
Stephens Initiates Bicycle Therapeutics(BCYC.US) With Hold Rating, Announces Target Price $25
Morgan Stanley Initiates Bicycle Therapeutics(BCYC.US) With Hold Rating, Announces Target Price $30
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
Bicycle Therapeutics Plc (NASDAQ:BCYC) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates